AU589726B2 - Novel derivatives of ((4-(4-(4-phenyl-1-piperazinyl)- phenoxymethyl)-1,3-dioxolan-2-yl) methyl)1H-imidazoles and 1H-1,2,4-triazoles - Google Patents

Novel derivatives of ((4-(4-(4-phenyl-1-piperazinyl)- phenoxymethyl)-1,3-dioxolan-2-yl) methyl)1H-imidazoles and 1H-1,2,4-triazoles

Info

Publication number
AU589726B2
AU589726B2 AU66853/86A AU6685386A AU589726B2 AU 589726 B2 AU589726 B2 AU 589726B2 AU 66853/86 A AU66853/86 A AU 66853/86A AU 6685386 A AU6685386 A AU 6685386A AU 589726 B2 AU589726 B2 AU 589726B2
Authority
AU
Australia
Prior art keywords
triazoles
imidazoles
phenoxymethyl
dioxolan
piperazinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU66853/86A
Other languages
English (en)
Other versions
AU6685386A (en
Inventor
Leo Jocobus Josef Backx
Jan Heeres
Alfonsus Guilielmus Knaeps
Josef Bertha August Thijssen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of AU6685386A publication Critical patent/AU6685386A/en
Application granted granted Critical
Publication of AU589726B2 publication Critical patent/AU589726B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU66853/86A 1985-12-23 1986-12-22 Novel derivatives of ((4-(4-(4-phenyl-1-piperazinyl)- phenoxymethyl)-1,3-dioxolan-2-yl) methyl)1H-imidazoles and 1H-1,2,4-triazoles Ceased AU589726B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81267085A 1985-12-23 1985-12-23
US812670 1985-12-23

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU16076/88A Division AU593736B2 (en) 1985-12-23 1988-05-12 Novel intermediates

Publications (2)

Publication Number Publication Date
AU6685386A AU6685386A (en) 1987-06-25
AU589726B2 true AU589726B2 (en) 1989-10-19

Family

ID=25210297

Family Applications (2)

Application Number Title Priority Date Filing Date
AU66853/86A Ceased AU589726B2 (en) 1985-12-23 1986-12-22 Novel derivatives of ((4-(4-(4-phenyl-1-piperazinyl)- phenoxymethyl)-1,3-dioxolan-2-yl) methyl)1H-imidazoles and 1H-1,2,4-triazoles
AU16076/88A Ceased AU593736B2 (en) 1985-12-23 1988-05-12 Novel intermediates

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU16076/88A Ceased AU593736B2 (en) 1985-12-23 1988-05-12 Novel intermediates

Country Status (18)

Country Link
EP (1) EP0228125B1 (en:Method)
JP (2) JPH0749428B2 (en:Method)
AT (1) ATE73799T1 (en:Method)
AU (2) AU589726B2 (en:Method)
CA (1) CA1292472C (en:Method)
CY (1) CY1825A (en:Method)
DE (1) DE3684431D1 (en:Method)
DK (2) DK164167C (en:Method)
ES (1) ES2032381T3 (en:Method)
FI (1) FI88505C (en:Method)
GR (1) GR3004114T3 (en:Method)
HK (1) HK46295A (en:Method)
IE (1) IE59564B1 (en:Method)
IL (1) IL81054A (en:Method)
NO (1) NO167917C (en:Method)
NZ (1) NZ218553A (en:Method)
PT (1) PT84007B (en:Method)
ZA (1) ZA869637B (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU624515B2 (en) * 1989-06-09 1992-06-11 Janssen Pharmaceutica N.V. Antifungal 4-(4-(4-(4-((2-(2,4-difluorophenyl)-2-(1H- azolylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)- 1-piperazinyl)phenyl)triazolones and imidazolones

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ223799A (en) * 1987-03-25 1989-12-21 Janssen Pharmaceutica Nv Azolylmethyl-dioxolanylmethoxyphenyl-piperazinyl-phenyl-triazolones and antimicrobial compositions
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
GR1000302B (el) * 1988-07-01 1992-05-12 Janssen Pharmaceutica Nv Μεθοδος παρασκευης παραγωγων 2,4-διυδρο-3η-1,2,4-τριαζολ-3-ονης.
GR1000298B (el) * 1988-07-01 1992-05-12 Janssen Pharmaceutica Nv Μεθοδος παρασκευης παραγωγων 2,4-διυδρο-3η-1,2,4-τριαζολ-3-ονης.
GR1000297B (el) * 1988-07-01 1992-05-12 Janssen Pharmaceutica Nv Μεθοδος παρασκευης παραγωγων 2,4-διυδρο-3η-1,2,4-τριαζολ-3-ονης.
GR1000330B (el) * 1988-07-01 1992-06-25 Janssen Pharmaceutica Nv Μεθοδος παρασκευης παραγωγων 2,4 διυδρο-3η-1,2,4-τριαζολ-3-ονης.
GB8903592D0 (en) * 1989-02-16 1989-04-05 Boots Co Plc Therapeutic agents
CA2076257A1 (en) * 1991-09-13 1993-03-14 Jan Heeres 4-¬4-¬4-(4-hydroxyphenyl)-1- piperazinyl|phenyl|-5-methyl-3h -1,2,4-triazol-3-one derivatives
TW279864B (en:Method) * 1993-02-19 1996-07-01 Janssen Pharmaceutica Nv
ATE204875T1 (de) * 1993-12-21 2001-09-15 Schering Corp Fungizide tetrahydrofurane
WO1995019983A1 (en) * 1994-01-24 1995-07-27 Janssen Pharmaceutica N.V. Watersoluble azole antifungals
US5571811A (en) * 1994-07-12 1996-11-05 Janssen Pharmaceutica N.V. Sulfonamide derivatives of azolones
KR100227231B1 (ko) * 1994-10-27 1999-11-01 디르크 반테 아포리포프로테인-b 합성 억제제
US5625064A (en) * 1995-04-19 1997-04-29 Schering Corporation Process for the preparation of triazolones
TW457240B (en) * 1995-04-20 2001-10-01 Janssen Pharmaceutica Nv Novel triazolones as apolipoprotein-B synthesis inhibitors
AU6257596A (en) * 1995-06-19 1997-01-15 Schering Corporation Hydroxyalkyl-substituted triazolones antifungals
AU773405B2 (en) * 1996-11-12 2004-05-27 Sepracor, Inc. Hydroxyitraconazole enantiomer mixtures
CN1237172A (zh) * 1996-11-12 1999-12-01 塞普拉科公司 2r,4s,r,s－和2s,4r,r,s－羟基伊曲康唑－和羟基沙波康唑衍生物
TW593312B (en) * 1997-07-11 2004-06-21 Janssen Pharmaceutica Nv 2,4,4-trisubstituted-1,3-dioxolane antifungals
UA63954C2 (en) * 1997-07-11 2004-02-16 Janssen Pharmaceutica Nv (+/-) norcisapride, a process for the preparation thereof, intermediate compounds, composition based thereon for use in the manufacture of medicaments for treating gastro-intestinal disorders
WO1999018111A1 (en) * 1997-10-07 1999-04-15 Schering Corporation Crystalline antifungal glycine ester polymorph
KR20010094761A (ko) 1999-05-04 2001-11-01 디르크 반테 항진균 에테르
KR100342383B1 (ko) * 1999-06-17 2002-12-06 한국화학연구원 이소옥사졸리딘 유도체, 그의 제조 방법 및 그를 포함하는 살균제 조성물
AU2011254654B2 (en) * 2010-05-19 2016-01-07 Sandoz Ag Process for the preparation of chiral triazolones
ES2786374T3 (es) 2014-12-05 2020-10-09 Pulmocide Ltd Compuesto antimicótico
DK3298006T3 (da) 2015-05-21 2020-03-30 Pulmocide Ltd Antifungal 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorphenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl)piperazin-1-yl)-n-(2-hydroxycyclohexyl)benzamid eller et farmaceutisk acceptabelt salt deraf

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU559461B2 (en) * 1983-02-28 1987-03-12 Janssen Pharmaceutica N.V. ((4-(4-(4-phenyl-1-peperizinyl)phenoxymethyl)-1,3,-dioxo- lan-2-yl)methyl)-1h-imidazoles and 1,2,4-triazoles

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144346A (en) * 1977-01-31 1979-03-13 Janssen Pharmaceutica N.V. Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU559461B2 (en) * 1983-02-28 1987-03-12 Janssen Pharmaceutica N.V. ((4-(4-(4-phenyl-1-peperizinyl)phenoxymethyl)-1,3,-dioxo- lan-2-yl)methyl)-1h-imidazoles and 1,2,4-triazoles

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU624515B2 (en) * 1989-06-09 1992-06-11 Janssen Pharmaceutica N.V. Antifungal 4-(4-(4-(4-((2-(2,4-difluorophenyl)-2-(1H- azolylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)- 1-piperazinyl)phenyl)triazolones and imidazolones

Also Published As

Publication number Publication date
IL81054A (en) 1992-03-29
AU6685386A (en) 1987-06-25
DK164167B (da) 1992-05-18
NO865235D0 (no) 1986-12-22
IE863369L (en) 1987-06-23
CA1292472C (en) 1991-11-26
DK625586D0 (da) 1986-12-22
NO865235L (no) 1987-06-24
HK46295A (en) 1995-04-07
DK74691A (da) 1991-04-23
PT84007A (en) 1987-01-01
DK164167C (da) 1992-10-12
EP0228125A1 (en) 1987-07-08
JPH0749428B2 (ja) 1995-05-31
ATE73799T1 (de) 1992-04-15
JP2574656B2 (ja) 1997-01-22
CY1825A (en) 1995-12-01
DK74691D0 (da) 1991-04-23
AU593736B2 (en) 1990-02-15
FI88505C (fi) 1993-05-25
NO167917B (no) 1991-09-16
DK167356B1 (da) 1993-10-18
FI88505B (fi) 1993-02-15
DE3684431D1 (de) 1992-04-23
ZA869637B (en) 1988-08-31
JPS62158275A (ja) 1987-07-14
EP0228125B1 (en) 1992-03-18
ES2032381T3 (es) 1993-02-16
NZ218553A (en) 1990-06-26
PT84007B (pt) 1989-06-30
FI865257A7 (fi) 1987-06-24
NO167917C (no) 1991-12-27
DK625586A (da) 1987-06-24
JPH07285963A (ja) 1995-10-31
FI865257A0 (fi) 1986-12-22
AU1607688A (en) 1988-08-04
IL81054A0 (en) 1987-03-31
IE59564B1 (en) 1994-03-09
GR3004114T3 (en:Method) 1993-03-31

Similar Documents

Publication Publication Date Title
AU589726B2 (en) Novel derivatives of ((4-(4-(4-phenyl-1-piperazinyl)- phenoxymethyl)-1,3-dioxolan-2-yl) methyl)1H-imidazoles and 1H-1,2,4-triazoles
ES8507541A1 (es) Un procedimiento para la preparacion de 1h-imidazolez y 1h-1,2,4-triazoles.
AU617918B2 (en) 2-aminopyrimidinone derivatives
AU582601B2 (en) Benzoxazol-and benzothiazolamine derivatives
AU1358588A (en) 4-(4-(4-((2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3- dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl) triazolones
KR960009422B1 (en) 4-(ardylamino)piperidinebutanamide derivatives
AU4084889A (en) Antihypertensive 3-piperidinyl-indazole derivatives

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired